Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer|HER2-positive Breast Cancer
Interventions: DRUG: Nab-paclitaxel|DRUG: Carboplatin|DRUG: Herceptin
Sponsor: Ruijin Hospital